Full-Service Revenue Cycle Management (RCM) — Built for Results

Accelerate your financial performance with expert RCM services — from billing to collections.

We deliver end-to-end revenue cycle solutions designed to streamline your operations and maximize your cash flow.

Why Choose Our RCM Services?

Daily Billing, Not Monthly
Unlike competitors, we bill in real time — every day — so you get paid faster.

No Long-Term Contracts
We offer flexible, monthly contracts to keep things simple and client-focused.

HIPAA-Compliant & Technology-Driven
Our secure, advanced systems improve efficiency while ensuring full compliance.

98% First-Pass Claim Acceptance Rate
We collect on over 98% of claims on the first submission — well above industry standards.

15-20% Higher Collections
Our clients see 15-20% more in revenue compared to industry averages.

Certified Expert Coders
Our 1,200+ coders ensure precise, compliant coding for faster reimbursements and fewer rejections, keeping your revenue flowing steadily. Our team also handles all of the IVR’s.

Trusted. Nationally Approved. Physician Supported.

We specialize in delivering a comprehensive allograft portfolio, ensuring clinical excellence, safety, and nationwide accessibility.

Why Choose Our Allografts

• All Products on the National ASP List
  Every graft we offer is reimbursable and nationally recognized — giving providers peace of mind and financial clarity.

• Full Product Line Available
  From soft tissue to wound care and orthopedic applications, we deliver a complete solution for your allograft needs.

Expert Support You Can Trust

Our dedicated Medical Advisory Committee is available to answer clinical questions and provide real-time guidance — helping physicians make confident, evidence-based decisions.

Magnolia Consulting’s Exosome Program

Exosomes are nano-sized extracellular vesicles naturally secreted by mesenchymal stem cells (MSCs). These vesicles carry a rich mixture of signaling molecules, including cytokines, growth factors, and mRNA, that are being actively studied for their roles in intercellular communication and regenerative research.

Unlike live stem cells, exosome preparations are cell-free—they do not contain DNA or replicate. This makes them an innovative focus in regenerative science while avoiding the complexities of live-cell therapies.

Our Manufacturing Standards

Magnolia Consulting’s Exosome Program emphasizes quality, safety, and consistency. Production is conducted under Current Good Manufacturing Practice (cGMP) guidelines to ensure reliable and reproducible results.

Our process begins with carefully screened placental-derived MSCs. These cells are cultured under controlled laboratory conditions. Once expanded, they are stimulated to secrete exosomes into a conditioned medium. The exosomes are then isolated, purified, and analyzed to meet stringent quality standards.

Research Use Only

All exosome preparations offered through Magnolia Consulting are intended exclusively for research use. They are not approved by the FDA for the treatment, diagnosis, or prevention of any disease or condition.

While exosomes hold significant promise in regenerative applications, they are regulated as biologics and must undergo appropriate clinical testing. Clinical use requires an approved Investigational New Drug (IND) application or Biologics License Application (BLA).

We are committed to supporting the responsible development of exosome-based technologies in compliance with all applicable regulatory frameworks.

Why Placental-Derived MSCs?

As part of our commitment to advanced regenerative research, Magnolia Capital Consulting sources MSCs from placental tissue, known for its robust biological activity. Placental MSCs secrete a broad spectrum of signaling molecules—including exosomes—making them an excellent choice for research into intercellular communication and regenerative strategies.